Sector Chart Allogene Therapeutics, Inc.

Stocks

ALLO

US0197701065

Biotechnology & Medical Research

Market Closed - Nasdaq 00:00:00 05/09/2026 +04			5-day change	1st Jan Change
1.970 ^USD	-0.51%		-2.48%	+43.80%

09-02	Allogene Therapeutics, Inc. Announces Retirement of Geoffrey Parker as Chief Financial Officer, Effective November 6, 2026	CI
09-02	Allogene Therapeutics, Inc. Announces Retirement of Geoffrey Parker as Executive Vice President and Principal Financial Officer, Effective November 6, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ALLOGENE THERAPEUTICS, INC.	681M	-	-	-	-	-
WUXI APPTEC CO., LTD.	67.98B
ARGENX SE	64.94B
INSMED INCORPORATED	27.58B					-
WUXI BIOLOGICS (CAYMAN) INC.	25.74B
BIONTECH SE	26.06B					-